Skip to main content

Table 1 Comparison of vitamin concentration levels among healthy controls, benign breast disease patients and breast cancer patients (n = 216)

From: Study on the correlation between B vitamins and breast cancer

Variables (n = 216)

Healthy controls (n = 91)

Benign breast disease patients (n = 380)

Breast cancer patients (n = 87)

H

p-valueb

Median

Interquartile range

Median

Interquartile range

Median

Interquartile range

VitA(ng/ml)a

405.28

151.37

368.355

166.48

401.37

1488.19

2.212

0.331

VitD2(ng/ml)a

1.20

1.07

1.94

3.76

1.45

1.73

10.275

0.006

VitD3(ng/ml)a

16.8

5.93

19.71

13.33

18.685

11.78

2.661

0.264

VitK(ng/ml)a

0.19

0.20

0.12

0.15

0.17

0.20

6.443

0.040

VitE(ug/ml)a

13.38

6.84

7.795

4.79

11.90

7.34

29.964

 < 0.001

VitB1(ng/ml)a

0.66

0.31

1.335

1.07

1.155

0.94

58.426

 < 0.001

VitB2(ng/ml)a

4.36

5.31

5.025

7.47

4.575

4.06

2.455

0.293

VitB3(ng/ml)a

15.18

16.26

22.44

16.78

13.415

12.68

17.101

 < 0..001

VitB5(ng/ml)a

23.41

14.39

30.45

13.03

32.455

19.57

15.479

 < 0..001

VitB6(ng/ml)a

2.10

1.59

2.53

1.35

2.085

1.54

4.683

0.096

VitB7(ng/ml)a

0.17

0.46

0.12

0.20

0.17

0.25

4.146

0.126

VitB9(ng/ml)a

4.51

3.89

7.55

11.23

4.165

4.05

14.175

0.001

VitB12(ng/ml)a

0.02

0.02

0.245

0.03

0.235

0.03

4.258

0.119

VitC(ug/ml)a

6.83

3.88

5.465

6.76

4.78

6.49

11.164

0.004

  1. aResults are presented in the median (quartile range)
  2. bP values tested by kruskal–wallis H test